Simone, Simona http://orcid.org/0000-0002-2569-3558
Pronzo, Virginia http://orcid.org/0000-0002-3955-6319
Pesce, Francesco http://orcid.org/0000-0002-2882-4226
Bavaro, Davide Fiore http://orcid.org/0000-0002-4833-7118
Infante, Barbara http://orcid.org/0000-0003-1815-5361
Mercuri, Silvia
Schirinzi, Annalisa http://orcid.org/0000-0001-9826-7907
Panaro, Antonella http://orcid.org/0000-0002-8409-4870
Conte, Eleonora http://orcid.org/0009-0000-3986-3178
Belati, Alessandra http://orcid.org/0000-0001-5455-8964
Troise, Dario http://orcid.org/0000-0003-2648-6021
Pontrelli, Paola http://orcid.org/0000-0002-7654-8318
Conserva, Francesca http://orcid.org/0000-0003-2863-864X
Gallo, Pasquale http://orcid.org/0000-0001-8914-2600
Panico, Maddalena
Spilotros, Marco http://orcid.org/0000-0003-1237-3018
Lucarelli, Giuseppe http://orcid.org/0000-0001-7807-1229
Saracino, Annalisa http://orcid.org/0000-0001-9558-208X
Stallone, Giovanni http://orcid.org/0000-0002-2862-9017
Di Serio, Francesca http://orcid.org/0000-0001-6089-1165
Ditonno, Pasquale http://orcid.org/0000-0001-7718-7676
Gesualdo, Loreto http://orcid.org/0000-0002-4861-0911
Funding for this research was provided by:
Università degli Studi di Bari Aldo Moro
Article History
Received: 18 April 2023
Accepted: 5 January 2024
First Online: 23 May 2024
Declarations
:
: LG received fees from FRESENIUS, ESTOR, WERFEN, ASTELLAS, ASTRAZENECA, TRAVERE, SANDOZ, SANOFI, BAXTER, MUNDIPHARMA, ESTOR, PHARMADOC, RETROPHIN, TRAVERE, ASTRAZENECA, GSK, NOVARTIS, CHINOOK, ROCHE, MEDTRONIC for activities of invited speaker and consultant.
: The Local Ethics Committees approved the study protocol (study n°6845, prot. n°0050551).
: Written informed consent was obtained before enrolment.